Antibiotics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.5 | Q1 | 87.9% | 1.276 | Q1 | 89.3% |
| 2024 | 4.6 | Q1 | 88.3% | 1.114 | Q1 | 86.8% |
| 2023 | 4.3 | Q1 | 81.4% | 0.920 | Q1 | 83.5% |
| 2022 | 4.8 | Q1 | 81.1% | 0.792 | Q1 | 80.3% |
| 2021 | 5.2 | Q2 | 80.5% | 0.785 | Q1 | 80.7% |
| 2020 | — | — | 0.960 | Q1 | 84.5% | |
| 2019 | — | — | 1.173 | Q1 | 88.8% | |
| 2018 | — | — | 1.121 | Q1 | 86.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2079-6382
region
Western Europe
coverage
2010, 2012-2026
